UK markets closed

Vor Biopharma Inc. (VOR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.3700+0.1600 (+7.24%)
At close: 04:00PM EDT
2.3300 -0.04 (-1.69%)
After hours: 06:19PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.2100
Open2.2400
Bid2.3400 x 200
Ask2.3700 x 300
Day's range2.2100 - 2.3800
52-week range1.6200 - 5.7000
Volume482,172
Avg. volume295,188
Market cap161.56M
Beta (5Y monthly)-0.39
PE ratio (TTM)N/A
EPS (TTM)-1.7500
Earnings date09 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est14.69
  • GlobeNewswire

    Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

    Trem-cel and VCAR33ALLO clinical trial data expected in the second half of 2024VCAR33ALLO granted Fast Track and Orphan Drug Designation by U.S. Food & Drug Administration Cash runway extends into second half of 2025 CAMBRIDGE, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today reported financial results for the three-month period and full year ended December 31, 2023, and provided a business update. “We are very pleased w

  • GlobeNewswire

    Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of March 1, 2024, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 4,250 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 6,375 shares of Vor Bio’s common stock to two newly hired employees. The foregoing stock

  • GlobeNewswire

    Vor Bio to Participate in Upcoming Investor Conferences

    CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: Barclays 26th Annual Global Healthcare ConferenceFireside Chat: Tuesday, March 12, 2024 at 4:35 pm ET Location: Miami, FL A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com. H.C. Wainwright 2nd Annual Cell Therapy V